April 29th 2025
Early actions by the new administration signal major changes in health policy, taxes, and pharmaceutical pricing.
US Payer Perspectives on Evidence for Formulary Decision Making
May 10th 2012To improve formulary design processes and support payers in providing more effective healthcare, policy makers should consider involving commercial payers in the development of comparative effectiveness research and creation of research and treatment guidelines.
Read More
Infused Chemotherapy Use in the Elderly After Patent Expiration
As calls for improving the quality and cost efficiency of oncology increase, future empirical work is needed to examine the responsiveness of oncologists' treatment decision making to incentives among patients of all ages and insurance types.
Read More
Care by Cell Phone: Text Messaging for Chronic Disease Management
Cell phone“based text messaging may be used to feasibly support chronic disease management and engagement in diabetes self-care behaviors for some patients.
Read More